New York State Common Retirement Fund’s Inspire Medical Systems INSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.23M | Buy |
72,413
+1,528
| +2% | +$72.5K | ﹤0.01% | 1268 |
|
|
2026
Q1 | $3.66M | Buy |
70,885
+2,111
| +3% | +$148K | 0.01% | 1144 |
|
|
2025
Q4 | $6.34M | Buy |
68,774
+18,527
| +37% | +$1.77M | 0.01% | 940 |
|
|
2025
Q3 | $3.73M | Sell |
50,247
-141,021
| -74% | -$14.3M | ﹤0.01% | 1199 |
|
|
2025
Q2 | $24.8M | Buy |
191,268
+8,518
| +5% | +$1.24M | 0.03% | 370 |
|
|
2025
Q1 | $29.1M | Buy |
182,750
+35,071
| +24% | +$6.34M | 0.04% | 303 |
|
|
2024
Q4 | $27.4M | Sell |
147,679
-23,580
| -14% | -$4.58M | 0.04% | 346 |
|
|
2024
Q3 | $36.1M | Sell |
171,259
-15,867
| -8% | -$2.76M | 0.05% | 277 |
|
|
2024
Q2 | $25M | Buy |
187,126
+116,909
| +166% | +$22.1M | 0.03% | 414 |
|
|
2024
Q1 | $15.1M | Buy |
70,217
+48,317
| +221% | +$9.47M | 0.02% | 647 |
|
|
2023
Q4 | $4.46M | Sell |
21,900
-4,927
| -18% | -$798K | 0.01% | 1161 |
|
|
2023
Q3 | $5.32M | Sell |
26,827
-21,909
| -45% | -$5.53M | 0.01% | 1085 |
|
|
2023
Q2 | $15.8M | Buy |
48,736
+13,980
| +40% | +$3.99M | 0.02% | 676 |
|
|
2023
Q1 | $8.14M | Sell |
34,756
-16,534
| -32% | -$4.18M | 0.01% | 971 |
|
|
2022
Q4 | $12.9M | Buy |
51,290
+6,901
| +16% | +$1.47M | 0.02% | 759 |
|
|
2022
Q3 | $7.87M | Sell |
44,389
-7,043
| -14% | -$1.42M | 0.01% | 956 |
|
|
2022
Q2 | $9.39M | Sell |
51,432
-9,950
| -16% | -$1.98M | 0.01% | 907 |
|
|
2022
Q1 | $15.8M | Buy |
61,382
+24,778
| +68% | +$5.66M | 0.02% | 757 |
|
|
2021
Q4 | $8.42M | Buy |
36,604
+5,271
| +17% | +$1.29M | 0.01% | 1085 |
|
|
2021
Q3 | $7.3M | Sell |
31,333
-3,200
| -9% | -$668K | 0.01% | 1146 |
|
|
2021
Q2 | $6.67M | Sell |
34,533
-7,110
| -17% | -$1.41M | 0.01% | 1210 |
|
|
2021
Q1 | $8.62M | Buy |
41,643
+2,560
| +7% | +$544K | 0.01% | 1031 |
|
|
2020
Q4 | $7.35M | Buy |
39,083
+1,801
| +5% | +$294K | 0.01% | 1099 |
|
|
2020
Q3 | $4.81M | Buy |
37,282
+546
| +1% | +$60.2K | 0.01% | 1178 |
|
|
2020
Q2 | $3.2M | Buy |
36,736
+10,630
| +41% | +$817K | ﹤0.01% | 1336 |
|
|
2020
Q1 | $1.57M | Buy |
26,106
+2,542
| +11% | +$188K | ﹤0.01% | 1525 |
|
|
2019
Q4 | $1.75M | Buy |
23,564
+109
| +0.5% | +$7.01K | ﹤0.01% | 1682 |
|
|
2019
Q3 | $1.43M | Buy |
23,455
+8,555
| +57% | +$563K | ﹤0.01% | 1805 |
|
|
2019
Q2 | $904K | Buy |
14,900
+3,000
| +25% | +$162K | ﹤0.01% | 2067 |
|
|
2019
Q1 | $676K | Buy |
11,900
+3,200
| +37% | +$173K | ﹤0.01% | 2165 |
|
|
2018
Q4 | $368K | Hold |
8,700
| – | – | ﹤0.01% | 2420 |
|
|
2018
Q3 | $366K | Hold |
8,700
| – | – | ﹤0.01% | 2561 |
|
|
2018
Q2 | $310K | Buy |
+8,700
| New | +$281K | ﹤0.01% | 2671 |
|
Other funds holding INSP
SCM
DM
New York State Common Retirement Fund's INSP Position: Q2 2026 in Review
New York State Common Retirement Fund increased its Inspire Medical Systems (INSP) stake by 2.2% in Q2 2026, buying an estimated $72.5K and bringing the position to 72,413 shares worth $3.23M. The position accounts for ﹤0.01% of the portfolio, ranked #1268.
New York State Common Retirement Fund first reported a position in INSP in Q2 2018 and has held it in 33 quarters since. The position peaked at $36.1M in Q3 2024. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.
- New York State Common Retirement Fund held 72,413 shares of Inspire Medical Systems worth $3.23M as of Q2 2026.
- New York State Common Retirement Fund bought 1,528 Inspire Medical Systems shares in Q2 2026, an estimated $72.5K.
- Inspire Medical Systems made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1268 holding.
- New York State Common Retirement Fund first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 33 quarters since.
- New York State Common Retirement Fund's Inspire Medical Systems position peaked at $36.1M in Q3 2024.
- 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.
Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.